TriSalus Life Sciences In...

NASDAQ: TLSI · Real-Time Price · USD
4.61
0.73 (18.81%)
At close: Aug 15, 2025, 3:59 PM
4.60
-0.22%
After-hours: Aug 15, 2025, 07:51 PM EDT

TriSalus Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
35.99M 32.14M 29.43M 26.89M 24.73M 21.98M 18.51M 16.02M 14.74M 13.01M 12.4M 11.74M 7.81M 4.94M 2.57M n/a n/a n/a
Cost of Revenue
5.52M 4.63M 4.1M 3.47M 3.05M 2.91M 2.6M 2.84M 2.95M 2.54M 2.26M 1.48M 774K 410K 34K n/a n/a n/a
Gross Profit
30.47M 27.51M 25.33M 23.42M 21.68M 19.07M 15.9M 13.18M 11.79M 10.47M 10.14M 10.26M 7.04M 4.53M 2.53M n/a n/a n/a
Operating Income
-30.98M -31.82M -36.18M -42.72M -52.45M -55.71M -54.15M -51.8M -41.44M -30.29M -28.06M -17.43M -10.13M -10.62M -3.04M -2.01M -1.2M -416.49K
Interest Income
423K 386K 404K 591K 549K 488K 431K 292K 225K 214K 180K 82.92K 52.58K 30.37K 64K 59.38K 40.71K 37.92K
Pretax Income
-31.17M -27.21M -30.05M -55.45M -54.47M -64.11M -59.17M -46.2M -52.86M -36.49M -36.09M -10.66M -698.11K -2.73M 4.77M 1.77M -98.36K -477.23K
Net Income
-31.88M -27.21M -30.06M -55.46M -54.35M -63.99M -59.04M -46.07M -52.88M -36.52M -36.12M -10.68M -726.31K -2.73M 4.77M 1.77M -98.36K -477.23K
Selling & General & Admin
47.06M 44.2M 43.8M 43.76M 46.61M 45.06M 40.55M 36.84M 29.65M 21.53M 19.85M 13.07M 7.36M 7.85M 3.04M 2.01M 1.2M 416.49K
Research & Development
14.4M 15.14M 17.7M 22.38M 27.53M 29.73M 29.51M 28.14M 23.58M 22.23M 21.36M 19.46M 14.65M 9.14M 4.37M n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a -25K -25K -25K -56K -31K -33K -33K -2K -2K n/a n/a n/a n/a
Operating Expenses
61.45M 59.34M 61.51M 66.14M 74.14M 74.78M 70.06M 64.98M 53.23M 38.25M 35.69M 22.65M 12.12M 12.62M 3.04M 2.01M 1.2M 416.49K
Interest Expense
2M 4.3M 3.09M 2.02M 887K 14K 16K 14K 10K 6K 1K 7.92K 26.58K 29.37K 64K 59.38K 40.71K 37.92K
Selling & Marketing Expenses
27.05M 25.89M 25.84M 24.43M 22.98M 20.47M 17.03M 15.29M 13.63M 13.28M 12.74M 8.88M 5.85M 2.71M n/a n/a n/a n/a
Cost & Expenses
66.97M 63.96M 65.61M 69.61M 77.33M 77.84M 72.8M 67.96M 56.18M 40.43M 37.58M 23.72M 12.5M 12.99M 3.04M 2.01M 1.2M 416.49K
Income Tax Expense
10K 14K 12K 14K 11K 17K 9K 14K 14K 29.2K 32.2K 26.2K 26.2K -2K n/a n/a n/a n/a
Shares Outstanding (Basic)
32.9M 28.53M 26.5M 26.5M 23.9M 23.32M 26.47M 26.47M 26.47M 26.47M 29.61M 31.25M 31.25M 31.25M 31.25M 31.25M 31.25M 31.25M
Shares Outstanding (Diluted)
32.9M 28.53M 26.5M 26.5M 23.9M 23.32M 26.47M 26.47M 26.47M 26.47M 29.61M 31.25M 31.25M 31.25M 31.25M 31.25M 31.25M 31.25M
EPS (Basic)
-1.19 -1.13 -1.34 -2.27 -2.2 -2.52 -2.23 -1.65 -1.86 -1.25 -1.19 -0.34 -0.02 -0.09 0.15 0.06 -0.00 -0.02
EPS (Diluted)
-1.19 -1.13 -1.34 -2.27 -2.2 -2.52 -2.23 -1.65 -1.86 -1.25 -1.19 -0.34 -0.02 -0.09 0.15 0.06 -0.00 -0.02
EBITDA
-26.26M -22.17M -26.2M -52.66M -52.35M -60.39M -57.31M -34.02M -41.18M -27.48M -25.16M -10.25M -422.44K -2.46M 4.79M 1.79M -92.27K -473.93K
EBIT
-19.46M -22.91M -26.96M -53.43M -53.45M -63.96M -59.01M -46.04M -52.85M -36.48M -36.09M -10.66M -698.11K -2.73M 4.77M 1.77M -95.06K -473.93K
Depreciation & Amortization
534K 741K 757K 766K 1.1M 1.04M 1.04M 780K 451K 307K 398K 609K 3.13M 4.29M 3.98M 3.83M 1.14M -22.82K